概述
EASL Clinical Practice Guidelines (CPG) on the
management of cholestatic liver diseases define the use
of diagnostic, therapeutic and preventive modalities,
including non-invasive and invasive procedures, in the
management of patients with cholestatic liver diseases.
They are intended to assist physicians and other healthcare
providers as well as patients and interested individuals
in the clinical decision-making process by
describing a range of generally accepted approaches
for the diagnosis, treatment and prevention of specific
cholestatic liver diseases. The clinical care for patients
with cholestatic liver diseases has advanced considerably
during recent decades thanks to growing insight into
pathophysiological mechanisms and remarkable methodological
and technical developments in diagnostic
procedures as well as therapeutic and preventive
approaches. Still, various aspects in the care of patients
with cholestatic disorders remain incompletely resolved.
The EASL CPG on the management of cholestatic liver
diseases aim to provide current recommendations on the
following issues:
